Cheema Amal W, Sutton Erica J, Beck Annika T, Cuellar Idali, Moreno Garzon Giovanna G, Hernandez Valentina, Lindor Noralane M, Shaibi Gabriel Q, Kullo Iftikhar J, Sharp Richard R
Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA.
Biospecimens Accessioning and Processing, Mayo Clinic, Scottsdale, Arizona, USA.
Public Health Genomics. 2021 Feb 16;24(1-2):44-53. doi: 10.1159/000513219.
The aim of the study was to characterize experiences of Latino participants receiving genomic screening results.
Participants were recruited at a federally qualified health center in the USA. In-person, semi-structured interviews were conducted in either Spanish or English by a bilingual, bicultural interviewer. Questions focused on motivations for pursuing genomic sequencing, concerns about receiving genomic screening results, and perceived benefits of receiving genomic information. Interviews were audio-recorded, transcribed, and translated.
Fifty individuals completed an interview; 39 were conducted in Spanish. Participants described mixed motivations for pursuing genomic screening. Participants viewed the benefits of genomic screening in relation to not only their personal health but to the health of their families and their communities. Participants tended to have few concerns about genomic screening. Those concerns related to potential loss of privacy, misuses of genomic information, and the possibility of receiving distressing results. Some participants had misunderstandings about the scope of the test and the potential implications of their results. Most felt it was better to know about a genetic predisposition to disease than to remain uninformed. Participants felt that genomic screening was worthwhile.
This is one of the first studies to examine the experiences of Latino individuals receiving genomic screening results. Our results suggest that many Latino patients in the US see value in genomic screening and have limited concerns about its potential to cause harm. These results inform ongoing efforts to increase the availability of genomic medicine to underrepresented populations and add to our understanding of sociocultural drivers in the adoption of precision medicine.
本研究旨在描述拉丁裔参与者接收基因组筛查结果的经历。
在美国一家符合联邦资质的健康中心招募参与者。由一位双语、双文化的访谈者用西班牙语或英语进行面对面的半结构化访谈。问题集中在进行基因组测序的动机、对接收基因组筛查结果的担忧以及接收基因组信息的感知益处。访谈进行录音、转录和翻译。
50人完成了访谈;其中39次访谈用西班牙语进行。参与者描述了进行基因组筛查的复杂动机。参与者认为基因组筛查的益处不仅关乎他们个人的健康,还关乎其家人和社区的健康。参与者对基因组筛查往往没什么担忧。这些担忧涉及隐私可能泄露、基因组信息被滥用以及收到令人苦恼的结果的可能性。一些参与者对检测范围及其结果的潜在影响存在误解。大多数人认为了解疾病的遗传易感性比一无所知要好。参与者觉得基因组筛查是值得的。
这是首批研究拉丁裔个体接收基因组筛查结果经历的研究之一。我们的结果表明,美国许多拉丁裔患者认为基因组筛查有价值,且对其可能造成伤害的担忧有限。这些结果为当前旨在增加基因组医学在代表性不足人群中的可及性的努力提供了信息,并增进了我们对采用精准医学的社会文化驱动因素的理解。